D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a ...

As I have posted, I am a top 8 predictor on Metaculus out of 34617 people according to Metaculus for baseline accuracy. I was ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

Republican Vivek Ramaswamy will launch his bid for Ohio governor on Feb. 24 in his native Cincinnati, with ensuing events in ...

Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

On January 28, 2025, Evaxion was given until May 12, 2025, to formally evidence compliance with Nasdaq listing rule 5550 (b) (1) requiring stockholders’ equity of at least $2.5 million. The company ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...